LEDS [SemiLEDs] 8-K:
[]
BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)
[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 5 EX-32.2]
UMC [UNITED MICROELECTRONICS] 6-K: (Original Filing)
[Description 99.1 Announcement on 2012/10/30: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2012/10/31: UMC announced its unconsolidated operating results for the third quarter of 2012 99.3 Announcement on 2012/10/31: To announce related materials on disposal of common shares of PARADE TECHNOLOGIES LTD. on behalf of UMC Capital Corporation 99.4 Announcement on 2012/11/07: To announce] [FORM 6-K November 19, 2012 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 11/19/2012 6-K 1 htm_7197.htm LIVE FILING]
BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2012
[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 5 EX-32.2]
UMC [UNITED MICROELECTRONICS] 6-K: Description 99.1 Announcement on 2012/10/30: To announce related
[Description 99.1 Announcement on 2012/10/30: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2012/10/31: UMC announced its unconsolidated operating results for the third quarter of 2012 99.3 Announcement on 2012/10/31: To announce related materials on disposal of common shares of PARADE TECHNOLOGIES LTD. on behalf of UMC Capital Corporation 99.4 Announcement on 2012/11/07: To announce] [FORM 6-K November 19, 2012 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 11/19/2012 6-K 1 htm_7197.htm LIVE FILING]
CPHI [CHINA PHARMAS,] DEF 14A: SCHEDULE 14A INFORMATION o Check the appropriate box:
[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, . Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]
CTC [IFM Investments] 6-K: (Original Filing)
[Century 21 China Real Estate Reports Third Quarter 2012 Unaudited Financial Results Bottom-Line Performance Continues to Improve Year on Year; Continued Positive Operating Cash Flow BEIJING, China, November 16, 2012 - IFM Investments Limited (NYSE: CTC) (Century 21 China Real Estate or the Company), a leading comprehensive real estate services provider and the exclusive franchisor for the CENTURY 21 ®] [FORM 6-K 2012 IFM INVESTMENTS LIMITED 26/A, East Wing, Hanwei Plaza No.7 Guanghua Road, Chaoyang District Beijing, 100004 Peoples Republic of China Form 20-F x Form 40-F o o o o No x S Number Description of Document 99.1]
